MENU
ESPR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Esperion Therapeutics (ESPR) Ownership - Who owns Esperion Therapeutics?
Esperion Therapeutics Inc is a pharmaceutical company... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
3891 Ranchero Drive
Phone
+1 734 887-3903
Employees
240
Web
https://www.esperion.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
410.41M
P/E Ratio
N/A
Total Cash
114.63M
Projected Growth
N/A
Total Debt
297.78M
Revenue
259.57M
Risk (Beta)
2.56
Dividend Yield
N/A
Total Cash/Share
0.57
Total Debt/Equity
N/A
Revenue/Share
1.37 USD as % of share price
Fundamentals
ESPR
Capitalization
410M
P/E Ratio
N/A
Risk (Beta)
2.56
Dividend Yield
N/A
Total Cash
115M
Total Cash/Share
0.57
Total Debt
298M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.37%
Revenue
260M
ROE
N/A
Book Value
-426.21M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.85
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
197K
Current Ratio
1.18
Current Revenue Per Employee
213799.34
Dividends Per Share - Security
N/A
EBITDA
-88.48M
Float
N/A
Float - Current
N/A
Gross Income Margin
51.48
Revenue To Assets
-43.96
Shares Held By Institutions
222M
Shares Outstanding - Current
200M
Total Liabilities
750M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-6.818
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ESPR showed earnings on August 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a developer of biopharmaceutical products
Industry PharmaceuticalsGeneric
Profile
Fundamentals
Details
Industry
Biotechnology
Address
3891 Ranchero Drive
Phone
+1 734 887-3903
Employees
240
Web
https://www.esperion.com